Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products
(2002; 52 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoChapter 1 - Introduction
Ver el documentoChapter 2 - A Short History of Involvement in Drug Safety Monitoring by WHO
Ver el documentoChapter 3 - Partners in Pharmacovigilance
Ver el documentoChapter 4 - Pharmacovigilance in Drug Regulation
Ver el documentoChapter 5 - Pharmacovigilance in Clinical Practice
Ver el documentoChapter 6 - Pharmacovigilance in International Health
Ver el documentoChapter 7 - Conclusion and considerations for the future
Ver el documentoGlossary
Ver el documentoReferences
Ver el documentoBack Cover

The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products

World Health Organization 2002

WHO Collaborating Centre for International Drug Monitoring

WHO Library Cataloguing-in-Publication Data

The Importance of Pharmacovigilance. (Safety monitoring of medicinal products)

1. Drug monitoring
2. Pharmaceutical preparations - adverse effects
3. Adverse drug reaction reporting
4. Product surveillance, Postmarketing
5. Legislation, Drug I.Series

ISBN 92 4 159015 7 (NLM classification: QV 38)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Typeset and printed in the United Kingdom.


Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019